| CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2 D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ... British journal of cancer 109 (9), 2412-2423, 2013 | 150 | 2013 |
| Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis TL Spivey, L Uccellini, ML Ascierto, G Zoppoli, V De Giorgi, LG Delogu, ... Journal of translational medicine 9, 1-22, 2011 | 102 | 2011 |
| An immunologic portrait of cancer ML Ascierto, VD Giorgi, Q Liu, D Bedognetti, TL Spivey, D Murtas, ... Journal of translational medicine 9, 1-13, 2011 | 102 | 2011 |
| IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ... British journal of cancer 109 (1), 76-82, 2013 | 66 | 2013 |
| Melanoma NOS1 expression promotes dysfunctional IFN signaling Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ... The Journal of clinical investigation 124 (5), 2147-2159, 2014 | 51 | 2014 |
| Identification of a novel nidovirus in an outbreak of fatal respiratory disease in ball pythons (Python regius) L Uccellini, RJ Ossiboff, RE De Matos, JK Morrisey, A Petrosov, ... Virology journal 11, 1-6, 2014 | 49 | 2014 |
| IRF5 gene polymorphisms in melanoma. L Uccellini, V De Giorgi, Y Zhao, B Tumaini, N Erdenebileg, ME Dudley, ... Journal of Translational Medicine 10, 170, 2012 | 42 | 2012 |
| A genetic inference on cancer immune responsiveness E Wang, L Uccellini, FM Marincola Oncoimmunology 1 (4), 520-525, 2012 | 39 | 2012 |
| The immune-related role of BRAF in melanoma S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ... Mol Oncol. 2015 Jan;9(1):93-104. doi: 10.1016/j.molonc.2014.07.014. Epub …, 2015 | 35 | 2015 |
| HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations L Uccellini, FC Tseng, A Monaco, FM Shebl, R Pfeiffer, M Dotrang, ... Hepatology 56 (1), 86-94, 2012 | 34 | 2012 |
| The stable traits of melanoma genetics: an alternate approach to target discovery TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ... BMC genomics 13, 1-11, 2012 | 32 | 2012 |
| Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68 ML Ascierto, A Worschech, Z Yu, S Adams, J Reinboth, NG Chen, Z Pos, ... BMC cancer 11, 1-14, 2011 | 29 | 2011 |
| Antitumor vaccines, immunotherapy and the immunological constant of rejection E Wang, A Monaco, V Monsurró, M Sabatino, Z Pos, L Uccellini, J Wang, ... IDrugs: the investigational drugs journal 12 (5), 297, 2009 | 25 | 2009 |
| Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing MR O’Donnell, MH Larsen, TS Brown, P Jain, V Munsamy, A Wolf, ... Antimicrobial agents and chemotherapy 63 (4), 10.1128/aac. 01834-18, 2019 | 19 | 2019 |
| A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon E Wang, Y Zhao, A Monaco, L Uccellini, JM Kirkwood, ... Public Library of Science 7 (7), e40805, 2012 | 18 | 2012 |
| Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population S Tomei, S Adams, L Uccellini, D Bedognetti, V De Giorgi, N Erdenebileg, ... Medical Oncology 29, 3456-3461, 2012 | 16 | 2012 |
| Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era D Bedognetti, G Zoppoli, MR Sertoli, E Zanardi, P Blandini, L Uccellini, ... International journal of hematology 91, 342-344, 2010 | 10 | 2010 |
| Evaluation of CXCR3 and CCR5 polymorphisms and gene-expression as predictive biomarkers of clinical response to adoptive therapy in melanoma patients D Bedognetti, L Uccellini, E Wang, ME Dudley, Z Pos, ML Ascierto, ... JOURNAL OF IMMUNOTHERAPY 33 (8), 860-860, 2010 | 5 | 2010 |
| Prolonged lack of humoral response to influenza vaccine associated with a persistent depletion of B memory cells in non hodgkin's lymphoma patients treated with rituximab … D Bedognetti, G Zoppoli, E Zanardi, C Massucco, MR Sertoli, M Messina, ... Clinical Immunology, S84, 2010 | 4 | 2010 |
| IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ... Journal for ImmunoTherapy of Cancer 1, 1-1, 2013 | 1 | 2013 |
Davide BedognettiSidra Medical and Research Center在 sidra.org 的电子邮件经过验证
